Literature DB >> 30587411

Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis.

Yun Ge1, Man Huang1, Yong-Ming Yao2.   

Abstract

The IL-1 family comprises two anti-inflammatory cytokines (IL-37, IL-38), two receptor antagonists (IL-1ra, IL-36ra), and seven ligand agonists (IL-1α, IL-1β, IL-33, IL-36α, IL-36β, IL-36γ). The members of this family exert pleiotropic effects on intercellular signaling, leading to pro- or anti-inflammatory responses. They initiate potent inflammatory and immune responses by binding to specific receptors in the IL-1 receptor family, and their activities are repressed by naturally occurring inhibitors. Various immune cells produce and are regulated by these crucial molecules, which appear to be involved in the pathogenesis of diverse diseases including cancer as well as inflammatory and autoimmune disorders. Recent decades have seen substantial progress in understanding how the IL-1 family contributes to the development of sepsis. In this review, we will briefly introduce the IL-1 family and discuss its critical role in inflammatory and immune responses. The potential significance of IL-1 members in sepsis will also be explored, together with the clinical implications for treating this dangerous condition.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adaptive immunity; Inflammation; Innate immunity; Interleukin-1 family; Sepsis

Mesh:

Substances:

Year:  2018        PMID: 30587411     DOI: 10.1016/j.cytogfr.2018.12.004

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  17 in total

1.  Bioinformatics-Based Study to Investigate Potential Differentially Expressed Genes and miRNAs in Pediatric Sepsis.

Authors:  Kexin Xie; Shan Kong; Fuxing Li; Yulin Zhang; Jing Wang; Weidong Zhao
Journal:  Med Sci Monit       Date:  2020-06-23

Review 2.  Pyroptosis in Osteoblasts: A Novel Hypothesis Underlying the Pathogenesis of Osteoporosis.

Authors:  Zhengbo Tao; Jinpeng Wang; Kaicheng Wen; Renqi Yao; Wacili Da; Siming Zhou; Yan Meng; Shui Qiu; Keda Yang; Yue Zhu; Lin Tao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-08       Impact factor: 5.555

Review 3.  Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality.

Authors:  Negar Moradian; Mahdi Gouravani; Mohammad Amin Salehi; Arash Heidari; Melika Shafeghat; Michael R Hamblin; Nima Rezaei
Journal:  Eur Cytokine Netw       Date:  2020-09-01       Impact factor: 3.450

4.  miR-23b Negatively Regulates Sepsis-Induced Inflammatory Responses by Targeting ADAM10 in Human THP-1 Monocytes.

Authors:  Wenying Zhang; Furong Lu; Yuliu Xie; Yao Lin; Tian Zhao; Shoubao Tao; Zhipeng Lai; Ning Wei; Ruoxuan Yang; Yiming Shao; Junbing He
Journal:  Mediators Inflamm       Date:  2019-10-31       Impact factor: 4.711

Review 5.  Crosstalk between Dendritic Cells and Immune Modulatory Agents against Sepsis.

Authors:  Guoying Wang; Xianghui Li; Lei Zhang; Abualgasim Elgaili Abdalla; Tieshan Teng; Yanzhang Li
Journal:  Genes (Basel)       Date:  2020-03-18       Impact factor: 4.096

6.  Interleukin-38 protects against sepsis by augmenting immunosuppressive activity of CD4+ CD25+ regulatory T cells.

Authors:  Yun Ge; Man Huang; Yao Wu; Ning Dong; Yong-Ming Yao
Journal:  J Cell Mol Med       Date:  2019-12-27       Impact factor: 5.310

7.  COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis.

Authors:  Kyung Mok Sohn; Sung Gwon Lee; Hyeon Ji Kim; Shinhyea Cheon; Hyeongseok Jeong; Jooyeon Lee; In Soo Kim; Prashanta Silwal; Young Jae Kim; Seungwha Paik; Chaeuk Chung; Chungoo Park; Yeon Sook Kim; Eun Kyeong Jo
Journal:  J Korean Med Sci       Date:  2020-09-28       Impact factor: 2.153

Review 8.  Gene-Edited Interleukin CAR-T Cells Therapy in the Treatment of Malignancies: Present and Future.

Authors:  Zhengchao Zhang; Lele Miao; Zhijian Ren; Futian Tang; Yumin Li
Journal:  Front Immunol       Date:  2021-07-27       Impact factor: 7.561

9.  IL-38 Alleviates Inflammation in Sepsis in Mice by Inhibiting Macrophage Apoptosis and Activation of the NLRP3 Inflammasome.

Authors:  Yun Ge; Juan Chen; Yanting Hu; Xinyi Chen; Man Huang
Journal:  Mediators Inflamm       Date:  2021-12-17       Impact factor: 4.711

10.  A COX-2/sEH dual inhibitor PTUPB ameliorates cecal ligation and puncture-induced sepsis in mice via anti-inflammation and anti-oxidative stress.

Authors:  Yan-Feng Zhang; Chen-Chen Sun; Jia-Xi Duan; Hui-Hui Yang; Chen-Yu Zhang; Jian-Bing Xiong; Wen-Jing Zhong; Cheng Zu; Xin-Xin Guan; Hui-Ling Jiang; Bruce D Hammock; Sung Hee Hwang; Yong Zhou; Cha-Xiang Guan
Journal:  Biomed Pharmacother       Date:  2020-02-27       Impact factor: 6.529

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.